HCAT (Health Catalyst) Beta: 1.7571 (As of Jun. 28, 2026)


HCAT Health Catalyst Inc HCAT
44 GF Score
Price $1.90
GF Value $5.06
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Health Catalyst Beta?

Health Catalyst HCAT +7.04% 44 Beta is 1.7571 as of Jun. 28, 2026. GuruFocus rates HCAT with a GF Score™ of 44/100 and a GF Value™ of $5.06 (Possible Value Trap). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), Health Catalyst's Beta is 1.7571.


Health Catalyst  (NAS:HCAT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Health Catalyst Beta Related Terms


Health Catalyst Beta Historical Data

* Premium members only.

The historical data trend for Health Catalyst's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Catalyst Beta Chart

Health Catalyst Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 1.16 1.85 1.91 1.84

Health Catalyst Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 1.70 1.42 1.84 1.86

HCAT vs CCLD, DH, OPRX: Beta Comparison

For the Health Information Services subindustry, Health Catalyst's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Catalyst Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's Beta distribution charts can be found below:

* The bar in red indicates where Health Catalyst's Beta falls into.


HCAT
44GF Score
Health Catalyst Inc HCAT
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health Catalyst Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.7571 mean?
Health Catalyst (HCAT) has a Beta of 1.7571 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Health Catalyst and its competitors.
Is Health Catalyst's Beta too high?
Health Catalyst's current Beta is 1.7571. Overall, Health Catalyst has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's Beta compare to CCLD and DH?
Health Catalyst's Beta of 1.7571 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Health Catalyst and its competitors. Health Catalyst's current Beta is 1.7571. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.06, compared to a current price of $1.90 — trading 62.5% below its estimated fair value. The current Beta is 1.7571. Health Catalyst's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Health Catalyst (HCAT), the current Beta is 1.7571 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health Catalyst (HCAT) Overvalued in 2026?

Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued. The current stock price of $1.90 is trading 62.5% below its estimated GF Value™ of $5.06. GuruFocus considers Health Catalyst to be Possible Value Trap.

Key valuation signals for HCAT:

  • Beta: 1.7571
  • GF Value™: $5.06 vs. price of $1.90 (62.5% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Health Catalyst Business Description

Other Exchanges 2YP:Germany
Address 10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
44GF Score

Get the complete analysis for HCAT

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.90
Price
$5.06
GF Value